Acidification of rat TRPV1 alters the kinetics of capsaicin responses
© Neelands et al; licensee BioMed Central Ltd. 2005
Received: 06 July 2005
Accepted: 28 September 2005
Published: 28 September 2005
Skip to main content
© Neelands et al; licensee BioMed Central Ltd. 2005
Received: 06 July 2005
Accepted: 28 September 2005
Published: 28 September 2005
TRPV1 (vanilloid receptor 1) receptors are activated by a variety of ligands such as capsaicin, as well as by acidic conditions and temperatures above 42°C. These activators can enhance the potency of one another, shifting the activation curve for TRPV1 to the left. In this study, for example, we observed an approximately 10-fold shift in the capsaicin EC50 (640 nM to 45 nM) for rat TRPV1 receptors expressed in HEK-293 cells when the pH was lowered from 7.4 to 5.5. To investigate potential causes for this shift in capsaicin potency, the rates of current activation and deactivation of whole-cell currents were measured in individual cells exposed to treatments of pH 5.5, 1 μM capsaicin or in combination. Acidic pH was found to both increase the activation rate and decrease the deactivation rate of capsaicin-activated currents providing a possible mechanism for the enhanced potency of capsaicin under acidic conditions. Utilizing a paired-pulse protocol, acidic pH slowed the capsaicin deactivation rate and was readily reversible. Moreover, the effect could occur under modestly acidic conditions (pH 6.5) that did not directly activate TRPV1. When TRPV1 was maximally activated by capsaicin and acidic pH, the apparent affinity of the novel and selective capsaicin-site competitive TRPV1 antagonist, A-425619, was reduced ~35 fold. This shift was overcome by reducing the capsaicin concentration co-applied with acidic pH. Since inflammation is associated with tissue acidosis, these findings enhance understanding of TRPV1 receptor responses in inflammatory pain where tissue acidosis is prevalent.
The vanilloid receptor 1 (TRPV1) is a member of the transient receptor potential family (TRP) of non-selective cation channels . These receptors are activated by a variety of lipids, acidic conditions and temperatures above 42°C. TRPV1 channels are tetramers composed of subunits with six transmembrane spanning domains, a pore loop between TM5 and TM6, and large N- and C-terminal intracellular domains . An intracellular domain just C-terminal to TM6 has been characterized as being important in the tetramerization of the channel and is coincident, in part, with the TRP box that is common among this family of ion channels .
The structural features of TRPV1 suggest that the primary ligand interaction site(s) and important regulatory mechanisms for the channel are intracellular. Indeed, multiple mutagenesis studies have shown that distinct intracellular regions are necessary for the binding of the exogenous TRPV1 agonist, capsaicin [4–6] although an extracellular site may also contribute to capsaicin binding . In contrast, extracellular site acidic residues have been implicated in proton activation (at pH < 6) and sensitization of TRPV1 . Further evidence that TRPV1 activation mechanisms are different for capsaicin and protons is provided by site-directed mutagenesis studies that disrupt capsaicin activation of the channel but leave proton actions intact . Despite these differences, there is evidence of some commonality in the gating of the channel in response to capsaicin or acidic pH activation .
Under pathological conditions multiple agents may simultaneously influence the activity of TRPV1 receptors. For instance, inflammation, ischemia, and infections result in elevated proton concentrations that can reduce the pH below 6 in the surrounding tissues . Acidic pH has been shown to stimulate a subpopulation of sensory nerves that are also activated by capsaicin . In addition, disruption of the TRPV1 gene attenuates proton-induced excitation of C-fibers , supporting a key role for TRPV1 in inflammatory pain. Treatment of TRPV1 receptors with capsaicin in the presence of other activators, including heat and acid results in a leftward shift of the capsaicin concentration response curve [11, 14]. This suggests additive or synergistic effects of acid or heat on TRPV1 activation by capsaicin. Such effects may occur through changes in capsaicin affinity or gating.
In this study, we found that acidic conditions (pH 6.5 to 4.0) alter both the activation and deactivation rate of capsaicin-activated currents, resulting in increased potency of capsaicin for TRPV1, with no change in efficacy. In contrast, the inhibitory potency of a novel competitive TRPV1 antagonist, A-425619, was significantly lowered when the two activators were co-applied. These results highlight the breadth of TRPV1 responses to different stimuli and the concept that this channel (as well as other TRP channels) may act not only as an integrator of different physical stimuli but also as a coincidence detector that may be important in determining the resultant physiological response to endogenous activators.
Acid dependent effects on the activation rate of capsaicin-activated responses. Increasing the acidity of the external solution during a 1 second pre-pulse resulted in an increase in the activation rate of capsaicin-evoked currents in rat TRPV1 expressing HEK-293 cells. Values are the mean ± SEM of the calculated activation rate (τ) using a single exponential fit.
Control (pH 7.4)
1176 ± 195
1021 ± 128
632.0 ± 86.5
242.7 ± 49.7
Comparison of the activation and deactivation kinetics of TRPV1. Mean activation and deactivation rates of responses from TRPV1 expressing HEK-293 cells following application of capsaicin (1 μM), acidic pH (5.5) or the combination. Row 3 represents activation and deactivation rates of currents evoked by 1 μM capsaicin following pre-exposure to acidic conditions (pH 5.5). Row 4 represents the activation rates of acid-evoked currents following pre-exposure to capsaicin (1 μM). The absolute value of rate measurements had slight day-to-day variations (possibly due to relative position of the drug application tube). Therefore values in this table are from cells in which direct comparisons can be made. Values are mean ± S.E.M.
1 μM Capsaicin
847 ± 119
845 ± 60
917 ± 307
56 ± 13
1 μM CAP (pH 5.5)
149.3 ± 17
10553 ± 1880
pH 5.5 (1 μM CAP)
93 ± 13
Comparison of the antagonist effects of A-425619 at TRPV1 responses evoked by different agonist(s). Values are the calculated IC50's and Hill slopes derived from fits of average normalized responses following the concentration-dependent inhibition by the TRPV1 competitive antagonist A-425619.
1 μM Capsaicin
30 nM CAP + pH 5.5
100 nM CAP + pH 5.5
1 μM CAP + pH 5.5
Recent evidence has illustrated the importance of TRPV1 channels as key integrators of painful stimuli. These receptors may be an important target for the development of novel analgesics. TRPV1 channels are directly activated by acid, heat and endogenous ligands such as NADA, OLDA and anandamide. In addition, inflammatory mediators such as bradykinin have been shown to sensitize TRPV1 through activation of protein kinases . The sensitized TRPV1 channel has heightened responses, and, under these conditions, activators bind the channel with higher affinity. For instance, TRPV1 is normally activated at temperatures greater than 42°C, but after the channel has been sensitized, temperatures <35°C can result in channel activation . Therefore, TRPV1 is not only responsive to multiple painful stimuli, but the additive or synergistic interactions between multiple stimuli make the receptor well suited as an integrator and coincidence detector of painful stimuli and thus underscore its potential as a significant contributor to nociception and hyperalgesia.
In this study we investigated the interaction of acid and capsaicin at TRPV1 in order to understand the mechanism by which these two activators modulate the effects of each other. We found that increasing the concentration of capsaicin or protons resulted in changes in the activation and deactivation rate of the activated currents. In addition, acid responses deactivated about 10-fold faster than capsaicin responses. These differences in deactivation rates may be due in part to the proposed different interaction sites of these two activators with the channel, i.e., the acid site has been proposed to be extracellular while capsaicin site is predominantly intracellular . Alternatively, the different deactivation rates may be the result of differences in the binding affinity of the activators to the channel.
It has previously been shown that acidic conditions can alter the TRPV1 affinity for capsaicin  and that mildly acidic conditions that cannot directly activate the channel can alter capsaicin responses . On a single channel level, acidic pH has been shown to potentiate capsaicin binding to TRPV1 as well as increase channel gating . In the present study, we have confirmed these results and demonstrated the novel findings that these changes are due to a slowing of the deactivation rate and an increase in the activation rate of capsaicin-activated currents at acidic pH. In combination, these changes in kinetics result in larger current amplitudes due to a higher probability of channels being bound by agonist. These current amplitudes are similar to what is observed at higher capsaicin concentrations at neutral pH. Thus, one would expect that under acidic conditions 1 μM capsaicin would produce a similar response at TRPV1 as 10 μM capsaicin does at physiological pH, consistent with the 10-fold increase in the apparent affinity for capsaicin at acidic pH.
In contrast to the increased activation rate, the deactivation rate of capsaicin-activated currents under acidic conditions was considerably slower than the rate observed with high capsaicin concentrations at pH 7.4 (see Figure 1 and 5). It is possible that binding of protons alters the conformation of the channel in a way that traps capsaicin so it cannot be released unless the proton interaction is terminated. A recent publication has shown that acidic conditions, in combination with agonists, lock the TWIK-2 channel in an open conformation that persists even after the pH is neutralized . The data in our study suggest that occupancy of the proton binding site of TRPV1 might result in an allosteric change in the receptor that prevents the release of capsaicin. However, a return to physiological pH could rapidly remove this trap and allows capsaicin to be released. The relatively fast deactivation rate of the acid response would provide opportunities for capsaicin to be released, although prolonged exposure to high concentrations of protons may dramatically reduce this probability. Further studies and kinetic modeling are needed to determine if this hypothesis can be supported.
Since TRPV1 can be activated by a variety of stimuli and these stimuli can cross-sensitize the receptor to each other, TRPV1 exhibits complex pharmacology. Cross-sensitization of the channel could potentially result in altered potency and/or efficacy of TRPV1 antagonists. Indeed, we have shown in these electrophysiological studies that application of capsaicin at acidic pH can significantly decrease the in vitro potency of A-425619, a competitive antagonist at the capsaicin-binding site of TRPV1, and that this shift becomes particularly dramatic under conditions at or approaching maximal channel activation. In contrast, A-425619 has similar potency (~20 nM) for blocking TRPV1 channel responses to half maximal concentrations of capsaicin or acid. It is possible that binding of the antagonist to the channel results in a conformational change that inhibits channel function independent of the mode of activation. Although there are multiple mechanisms for channel activation, a single site for antagonists may exist that is sufficient to prevent or modulate channel opening. This site most likely is the same or overlaps significantly with the site for capsaicin binding, since A-425619 is competitive with capsaicin .
We report the novel finding that acid alters both the activation and deactivation rates of capsaicin responses and thus provide a mechanism for the increase in potency of capsaicin, and perhaps other agonists, under acidic conditions. Since inflammation is associated with tissue acidosis, these results enhance understanding of the role of TRPV1 in inflammatory pain.
HEK-293 cells stably expressing the rat TRPV1 receptor were maintained at 37°C in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. Cells were plated onto glass coverslips coated with polyethyleneimine. Electrophysiological recordings were performed 1–4 days following plating.
HEK-293 cells were maintained at room temperature in an extracellular recording solution (pH 7.4, 325 mOsm) consisting of (in mM): 155 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 12 glucose. Patch-pipettes composed of boroscilicate glass (1B150F-3; World Precision Instruments, Inc., Sarasota, FL, USA), were pulled and fire-polished using a DMZ-Universal micropipette puller (Zeitz Instrumente GmbH, Munich, Germany). Pipettes (2–6 MΩ) were filled with an internal solution (pH 7.3, 295 mOsm) consisting of (in mM): 122.5 K-aspartate, 20 KCl, 1 MgCl2, 10 EGTA, 5 HEPES, 2 ATP·Mg. For experiments where pH was lowered (6.8 – 4.0) MES was used in place of HEPES in the external solution. No ASIC-like responses were evident in our TRPV1 expressing HEK cells but were recorded in HEK-293 null cells in response to application of acidic pH (unpublished observations). Standard whole-cell recording techniques were utilized for voltage-clamp studies using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA, U.S.A). Coverslips plated with HEK-293 cells were placed in a perfusion chamber and following establishment of whole-cell recording conditions bath perfusion (~2 ml/min) was initiated. Application of control bath solution through a multi-barrel application device with a common 360 μm polyimide tip (Cell Microcontrols, Norfolk, VA, U.S.A), positioned ~100 μm from the cell, was continued throughout the recording except during drug application. Each drug reservoir was connected to solenoid teflon valves that were controlled by a ValveLink16 system (AutoMate Scientific, CA, San Francisco, U.S.A). Drug application protocols were established using pCLAMP (Axon instruments) software that controlled rapid valve switching through the ValveLink system. Drugs were applied by gravity feed through the drug application device for durations described in the results section. Solution exchange times were determined by applying 90% external solution to an open tip electrode positioned at the same distance as during a typical recording. Following a delay of ~50 ms from the opening of the solenoid valve, currents activated at a rate of 72 ± 9 ms with a 10–90% rise time of ~120 ms (n = 4). Similarly, the current deactivated with an deactivation rate of 84 ± 16 ms (n = 4). These values give an approximation of the limitations of the drug exchange for this system across an open tip electrode and indicate that our measurements of activation and deactivation rates of whole cell currents should not be significantly affected by solution exchange times. Prior to and following each drug application external solution was applied through the application device to ensure rapid washout. Each drug application sequence was followed by a washout period of 90 to 120 seconds.
Capsaicin concentration response curves were generated by applying increasing concentrations of capsaicin for 4 seconds followed by a 90 second washout period. These responses were evoked at pH 7.4 and pH 5.5 and the responses were normalized due to large variation in peak amplitude between cells, and the subsequent average data was fitted with a four-parameter logistic equation (see below). To determine potential changes in the efficacy of capsaicin responses a separate experiment was performed comparing peak responses to 30 μM capsaicin at pH 5.5 and pH 7.4 on the same cell. Generally there was substantial rundown of the currents during the first few applications of 30 μM capsaicin. Therefore, comparisons between the responses to pH 5.5 and pH 7.4 were made after two consecutive applications of capsaicin produced similar responses.
Inhibitory concentration response curves were performed by applying the agonist(s) for 4 seconds followed by 8 seconds of co-application of agonist and antagonist. Current levels at the end of the application period were measured and normalized to the current amplitude at the end of a 12 second control application of agonist alone. Normalized responses were then plotted as a function of antagonist concentration and fitted with a four-parameter logistic equation (see below).
Data acquisition and analysis were performed using pCLAMP 9.0 and subsequent graphs were plotted and statistical analysis done using GraphPad Prism (Graphpad Software, San Diego, CA, U.S.A). Activation and deactivation rates were calculated in Clampfit using a single exponential equation provided with the software:
Agonist and antagonist concentration-response curves were fitted by a least-squares regression to the logistic equation provide in the GraphPad software:
A Schild plot for A-425619 was constructed by converting data from inhibitory concentration response curves obtained at different capsaicin concentrations (in the presence of acidic pH) to capsaicin concentration response curves under different concentrations of antagonist. The resulting curves were fit with the logistic equation shown above and the resulting EC50 were used to calculate the log dose ratio that was then plotted as a function of capsaicin concentration. A linear regression was then used to fit these data points.
All reagents were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.) except A-425619 (synthesized at Abbott Laboratories, Abbott Park, IL, U.S.A).
We would like to thank Arthur Gomtsyan and Chih-Hung Lee for the synthesis of A-425619 and Steve McGaraughty and Robert Moreland for their critical comments on the manuscript.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.